Visual & Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine Infusions
NEJM 314:869-873, Olivieri,N.F.,et al, 1986
Cogan Syndrome An Analysis of Reported Neurological Manifestations
The Neurologist 18:55-63, Antonios,N. and Silliman,S., 2012
Carbon Monoxide Poisoning and Sensorineural Hearing Loss
J Laryngol Otol 117:134-137, Hassan,M.S.,et al, 2003
Retinocochleocerebral Vasculopathy
Medicine 77:12-40, Petty,G.W.,et al, 1998
Hearing Loss in the Sjogren Syndrome
Ann Int Med 126:450-453, Tumiati,B.,et al, 1997
Serial Studies of Auditory Neurotoxicity in Patients Receiving Deferoxamine Therapy
Am J Med 83:1085-1090, Gallant,T.,et al, 1987
Acoustic Tumors:Atypical Features & Recent Diagnostic Tests
Neurol 33:211-221, Hart,R.G.,et al, 1983
Ototoxic Drugs & The Detection Of Ototoxicity
NEJM 301:213-214, Meyers,A.D., 1979
Cis-diamminedichloroplatinum (II) , A New Anticancer Drug
Ann Int Med 86:803-812, Rozencweig,M.,et al, 1977
Important Advances in Clinical Medicine
West J Med 123:128, Mosier,J.M.,et al, 1975